Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7502 p584
17 May 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Darzi advises on tackling NHS changes

Five pledges on how the NHS should handle changes to services are set out by Lord Darzi in his report “Leading local change”, published last week. This comes ahead of Lord Darzi’s final report on the NHS, expected June 2008.

The pledges — which primary care trusts will have a duty to “have regard to” — include making sure that change always benefits the patient, is based on good clinical evidence, is led locally instead of imposed nationally and depends on the involvement of patients, the public and other key partners. The final pledge is that existing services should not be withdrawn until the new service has proved itself.

Georgina Craig, lead on commissioning policy for the Company Chemists’ Association, believes that Lord Darzi’s five pledges are important, but largely self evident. “From a CCA perspective, it matters not that Lord Darzi has made these pledges, but that he and the Government are committed to honouring them in new and fundamentally different ways, moving forward,” she added.

Darzi’s report refers to eight key steps to deciding on substantive service changes to make the five pledges a reality. These eight steps are included in detailed operational guidance, “Changing for the better”, also published last week.

Over the next month, every strategic health authority in England will publish a clinically-led vision document for improving health and healthcare over the next decade. Lord Darzi is expected to publish his final report in June, which aims to enable and support the improvements identified locally.

All documents are available on the Darzi review website

NHS Reform Bill A new NHS Reform Bill — which will take forward any proposals arising from Lord Darzi’s next stage review that require primary legislation — was included in the Government’s draft legislative programme, published this week.

Back to Top


©The Pharmaceutical Journal